Dr. Paul Yamauchi
Claim this profileClinical Science Institute
Studies Psoriasis
Studies Atopic Dermatitis
11 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Paul Yamauchi is currently running
Eltrekibart
for Hidradenitis Suppurativa
This trial is testing a new medication called eltrekibart to find the most effective treatment for adults with moderate-to-severe hidradenitis suppurativa. The goal is to see if it can safely and effectively reduce symptoms by targeting inflammation pathways.
Recruiting0 awards Phase 25 criteria
GSK1070806
for Atopic Dermatitis
This study is parallel group, placebo-controlled dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK1070806 in adult participants with moderate to severe Atopic Dermatitis (AtD), who have previously been treated with medicated topical treatments or a biologic therapy.
Recruiting0 awards Phase 210 criteria
More about Paul Yamauchi
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Paul Yamauchi has experience with
- Placebo
- Lebrikizumab
- GSK1070806
- Deucravacitinib (BMS-986165)
- BIIB059 (litifilimab)
- BIIB059
Breakdown of trials Paul Yamauchi has run
Psoriasis
Systemic Lupus Erythematosus
Discoid Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Yamauchi specialize in?
Paul Yamauchi focuses on Psoriasis and Atopic Dermatitis. In particular, much of their work with Psoriasis has involved treating patients, or patients who are undergoing treatment.
Is Paul Yamauchi currently recruiting for clinical trials?
Yes, Paul Yamauchi is currently recruiting for 5 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Paul Yamauchi has studied deeply?
Yes, Paul Yamauchi has studied treatments such as Placebo, Lebrikizumab, GSK1070806.
What is the best way to schedule an appointment with Paul Yamauchi?
Apply for one of the trials that Paul Yamauchi is conducting.
What is the office address of Paul Yamauchi?
The office of Paul Yamauchi is located at: Clinical Science Institute, Santa Monica, California 90404 United States. This is the address for their practice at the Clinical Science Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.